Advertisement

Related Videos

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Focus on Optimized Dosing of Ibrutinib Panel Discussion

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Opportunities to Optimize Cancer Policies Panel Discussion

Advertisement

Advertisement




Oct
21
Today In Oncology
Bivalent CAR T-Cell Therapy Shows No Delayed Toxicity and Promising Survival in Recurrent Glioblastoma
Claudia Henschke, PhD, MD Finding Lung Cancer in Time
Starting Surveillance Colonoscopy After High-Risk Adenoma Removal When Is the Right Time
Evolving Strategies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
AI Model Based on Facial Image Analysis Estimates Biological Age and Mortality Risk in Patients With Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo